• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰亚急性硬化性全脑炎的研究历史。

The history of studies on subacute sclerosing panencephalitis in Poland.

作者信息

Kulczycki J

机构信息

I Department of Neurology, Institute of Psychiatry and Neurology, Warszawa.

出版信息

Folia Neuropathol. 1998;36(4):191-8.

PMID:10079599
Abstract

The main trends are described in the studies of subacute sclerosing panencephalitis conducted in Poland or abroad with participation of Polish scientists. The history of these studies began in the years 1957-1959 with the works of Wender and Osetowska and ends presently at the end of our century with extinction of SSPE as a result of consistently conducted obligatory vaccinations against measles. The studies of Polish authors involved the problems of clinical diagnosis using immunological, electrophysiological and neurological imaging methods. Neuropathological problems were also studied extensively. Parallely with similar studies in the foremost foreign centres trials of SSPE treatment were undertaken in Poland, in recent years by means of intracerebroventricular administration of interferons. An original Polish method was the treatment with inducers of endogenous interferons. After the introduction of vaccinations against measles epidemiological studies repeated in the whole country were introduced for the assessment of the results of this preventive measure. These studies are regarded as model ones at international level.

摘要

在波兰科学家参与下于波兰或国外开展的亚急性硬化性全脑炎研究描述了主要趋势。这些研究的历史始于1957 - 1959年温德和奥塞托夫斯卡的著作,目前随着因持续开展强制性麻疹疫苗接种导致亚急性硬化性全脑炎灭绝而在本世纪末结束。波兰作者的研究涉及使用免疫、电生理和神经影像学方法进行临床诊断的问题。神经病理学问题也得到了广泛研究。与国外主要中心的类似研究同时,近年来波兰通过脑室内注射干扰素对亚急性硬化性全脑炎进行了治疗试验。一种原创的波兰方法是使用内源性干扰素诱导剂进行治疗。在引入麻疹疫苗接种后,在全国重复进行了流行病学研究以评估这一预防措施的效果。这些研究在国际层面被视为典范。

相似文献

1
The history of studies on subacute sclerosing panencephalitis in Poland.波兰亚急性硬化性全脑炎的研究历史。
Folia Neuropathol. 1998;36(4):191-8.
2
[Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
Neurol Neurochir Pol. 1999 May-Jun;33(3):653-63.
3
[Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].[波兰引入疫苗接种前后麻疹与亚急性硬化性全脑炎(SSPE)之间的相关性分析]
Przegl Epidemiol. 1992;46(4):295-301.
4
[Evaluation of changes in the epidemiological situation of SSPE in Poland in the years 1977-1991 (in the course of 15 years after the introduction of mandatory antimeasles vaccination)].[1977 - 1991年波兰亚急性硬化性全脑炎流行病学状况变化评估(在实施强制性麻疹疫苗接种后的15年期间)]
Neurol Neurochir Pol. 1993 May-Jun;27(3):341-8.
5
[Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].[1984 - 1986年波兰的亚急性硬化性全脑炎(SSPE)。流行病学研究的第三阶段]
Przegl Epidemiol. 1988;42(3):205-10.
6
Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).麻疹、麻疹疫苗接种与亚急性硬化性全脑炎(SSPE)风险
Neurology. 1983 Dec;33(12):1558-64.
7
Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.麻疹、麻疹疫苗与亚急性硬化性全脑炎的流行病学研究
Pediatrics. 1977 Apr;59(4):505-12.
8
Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).德意志联邦共和国亚急性硬化性全脑炎(SSPE)的发病率、血清学诊断及流行病学特征以及麻疹的流行病学与疫苗接种政策
Dev Biol Stand. 1978;41:195-207.
9
[Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies].
Neurol Neurochir Pol. 2000 Sep-Oct;34(5):877-85.
10
Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.日本麻疹及麻疹疫苗接种后亚急性硬化性全脑炎的发病率
Int J Epidemiol. 1989 Sep;18(3):684-9. doi: 10.1093/ije/18.3.684.